Please wait while we load the requested 10-K report or click the link below:
Marrone Bio Innovations Reports Record Fourth Quarter and Fiscal Year 2013 Financial Results
Full year 2013 revenue more than doubles to $14.5 million
Produced Grandevo and Regalia at Michigan facility
Company on pace to release two new products in 2014
DAVIS, Calif., March 6, 2014Marrone Bio Innovations, Inc. (NASDAQ: MBII), a provider of bio-based pest management and plant health products, announced today financial results for the fourth quarter and full year ended December 31, 2013.
Financial Highlights for the Fourth Quarter of 2013
|||Revenues for the fourth quarter 2013 totaled $6 million, representing growth of 106%. Revenue for the full year 2013 totaled $14.5 million, representing growth of 104%|
|||Net loss of $10 million, compared to net loss of $17.1 million in the fourth quarter of 2012|
Our robust fourth quarter results capped a transformative year for Marrone Bio Innovations, said Pam Marrone, Chief Executive Officer of Marrone Bio Innovations. I am extremely pleased with the progress we have achieved in 2013. We continued to broaden our sales into high value specialty crops, launched into row crops in North America and also extended our commercial reach across the globe. Our commercial success in the fourth quarter as well as our numerous scientific and operational milestones in 2013 underscore our confidence that we will continue to lead the shift to biologically-based alternatives for pest management and plant health.
Recent Business Highlights
|||Passed the 1 million acres-treated milestone for biopesticide products in the United States|
The following information was filed by Marrone Bio Innovations Inc (MBII) on Thursday, March 6, 2014 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-K Annual Report statement of earnings and operation as management may choose to highlight particular information in the press release.
View differences made from one year to another to evaluate Marrone Bio Innovations Inc's financial trajectory
Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were
removed , and by Marrone Bio Innovations Inc.